Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples